Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women

Journal of Hypertension

Volumn 15, Issue 5, 1997, Pages 475-481

  Vanhala, Mauno J ^a   Kumpusalo, Esko A ^b   Pitkäjärvi, Timo K ^c   Notkola, Irma Leena ^b   Takala, Jorma K ^b  

^a Pieksamaki Dist Hlth Ctr   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Comm Hlth Ctr City of Tampere ^*  (Finland)

Author keywords

Abnormal glucose metabolism; Dyslipidemia; Hyperinsulinemia; Hypertension; Metabolic syndrome; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; FINLAND; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

EID: 0030961314     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715050-00002     Document Type: Article

References (28)

1. Modan M, Halkin H, Almong S, Lusky A, Eshkol A, Shefi M, et al.: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985, 75:809-817.
2. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
3. Eriksson H, Welin L, Wilhelmsen L, Larsson B, Ohlson LO, Svardsudd K. et al.: Metabolic disturbances in hypertension: results from the population study 'Men born in 1913'. J Intern Med 1992, 232: 389-395.
4. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381.
5. Lind L, Lithell H, Pollare T: Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens 1993, 11 (suppl 4):S11-S16.
6. Julius S: Sympathetic overactivity and the pathophysiology of the coronary risk in hypertension. Cardiovasc Risk Factors 1995, 5 (suppl 1):2-10.
7. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991, 337:382-386.
8. Bengtsson C, Bjökelund C, Lapidus L, Lissner L: Association of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden. BMJ 1993, 307:1385-1388.
9. Pyörälä K, Savolainen E, Kaukola S. Haapakoski J: Plasma insulin as a coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policeman Study population. Acta Med Scand 1985, 701: 38-52.
10. Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S. et al.: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952-957.
11. Mykkänen L, Laakso M, Pyörälä K: High plasma insulin level associated with coronary heart disease in the elderly. Am J Epidemiol 1993, 11:1190-1202.
12. Kaplan NM: The deadly quartet: upper-body adiposity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989, 149:1514-1520.
13. Fontbonne A, Cha A, Balkau B, Eschwege E: The insulin resistance syndrome and the Paris Prospective Study. Cardiovasc Risk Factors 1993, 1:36-43.
14. Despres J-P, Marette A: Relation of components of insulin resistance coronary disease risk. Curr Opin Lipidol 1994, 5:274-289.
15. Frayn KN, Coppack SW: Insulin resistance, adipose tissue and coronary heart disease. Clin Sci Colch 1992, 82:1-8.
16. Laakso M: The possible pathophysiology of insulin resistance syndrome. Cardiovasc Risk Factors 1993, 1:55-66.
17. WHO Expert Committee: Arterial Hypertension. Geneva: World Health Organization; 1978.
18. Penttilä IM, Voutilainen E, Laitinen O, Juutilainen P: Comparison of different analytic and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest 1981, 41:353-360.
19. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society prepared by the international task for the prevention of coronary heart disease. Nutr Metab Cardiovasc Dis 1992, 2:113-156.
20. Castelli WP: Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992, 70:3H-9H.
21. World Health Organization: Report of WHO Study Group on Diabetes Mellitus. Geneva: World Health Organization; 1985.
22. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993, 9:959-965.
23. Zamora-Conzales J, Yamamoto-Kimura L, Lerman-Garber I, CardosoSaldana G, Fajardo Gutierrez A. Posadas-Romero C: Clustering of metabolic disorders and hyperinsulinemia in Mexico City. Int J Obes 1996, 20:311-318.
24. Modan M, Halkin HH, Lusky A, Segal P, Fuchs Z, Chetrit A: Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study. Arteriosclerosis 1988, 8:227-236.
25. Lind L, Berne C, Lithell H: Prevalence of insulin resistance in essential hypertension. J Hypertens 1995, 13:1457-2462.
26. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381
27. Collins R, Peto R, McMahon S, Hebert P, Fiebach NH, Eberlein KA, et al.: Blood pressure, stroke, and coronary heart disease. Lancet 1990, 335:827-838.
28. Samuelsson O, Pennert K, Andersson O, Berglund G, Hedner T, Persson B, et al.: Diabetes mellitus and raised serum triglyceride concentration in treated hypertension - are they of prognostic importance? Observation study. BMJ 1996, 313:660-663.